US Customs / CBPCustoms TariffUSEUPublished: June 18, 2026
⚠️This content was analyzed by AI. Please verify with the original source.
USTR has initiated a Section 301 investigation into Germany's persistent underpayment for innovative pharmaceutical products.
[Impact on sellers shipping from Japan to EU] This is a US–Germany pharma trade dispute. Direct impact on Japan-origin cross-border sellers is currently limited, but escalation into retaliatory tariffs could affect EU-US supply chains. Please verify original